Safety of inhaled levofloxacin in people with cystic fibrosis: Data from UK and German Registries

20260 citationsJournal Articlehybrid Open Access

Authors

NJ. Simmonds · Royal Brompton Hospital

S.C Charman · Cystic Fibrosis Trust

J. Wosniok · Johannes Gutenberg University Mainz

Connor J. Haugh · Cystic Fibrosis Trust

Debora Santoro · Chiesi (Italy)

Stella Fiorini · Chiesi Foundation

Rémi Charretier ·

Abstract

LIS was generally safe although may be associated with a higher risk of haemoptysis. No difference in liver disease, tendon rupture or treatment discontinuation compared to other inhaled antibiotics was observed.

Topics & Keywords

Cystic Fibrosis Research Advances Nosocomial Infections in ICU Pneumonia and Respiratory Infections

Publication Details

Published in: Journal of Cystic Fibrosis

DOI: 10.1016/j.jcf.2026.03.012

Field-Weighted Citation Impact: 0.00

Command Palette

Safety of inhaled levofloxacin in people with cystic fibrosis: Data from UK and German Registries

Authors

Abstract

Topics & Keywords

Publication Details